Cobertura vacinal contra o HPV em adolescentes no Distrito Federal em comparação ao Centro-Oeste e Brasil (2014–2024)
DOI:
https://doi.org/10.61695/rcs.v4i1.95Palavras-chave:
papilomavírus humano, vacinação, cobertura vacinal, adolescente, saúde públicaResumo
Este estudo teve como objetivo analisar a evolução da cobertura vacinal contra o Papilomavírus Humano (HPV) em adolescentes de 10 a 14 anos no Distrito Federal, no período de 2014 a 2024, em comparação com a região Centro-Oeste e o Brasil. Trata-se de um estudo ecológico de série temporal, baseado em dados secundários do Painel de Cobertura Vacinal do Ministério da Saúde, considerando sexo, faixa etária, tipo de dose (D1, D2 e dose única) e tendência temporal. Observou-se queda acentuada da cobertura vacinal durante a pandemia de COVID-19, seguida de recuperação gradual a partir de 2022. O Distrito Federal apresentou desempenho superior ao da região Centro-Oeste e do país, embora sem diferença estatisticamente significativa. Persistiram desigualdades por sexo e idade, com maior cobertura entre meninas e adolescentes mais velhos. A introdução do esquema de dose única em 2024 mostrou-se uma estratégia promissora para ampliar a adesão vacinal. Os achados reforçam a necessidade de estratégias contínuas de imunização, com foco em campanhas escolares, comunicação direcionada e monitoramento das desigualdades regionais e demográficas.
Downloads
Referências
Brazil. Ministry of Health. Ministry of Health strengthens HPV vaccination strategy [Internet]. Brasília (DF): Ministry of Health; 2025 Mar 2 [cited 2025 Oct 29]. Available from: https://www.gov.br/saude/pt-br/assuntos/noticias/2025/marco/ministerio-da-saude-reforca-estrategia-de-vacinacao-contra-hpv
Brazil. Ministry of Health. Science guarantees: HPV vaccines are safe and protect children and adolescents [Internet]. Brasília (DF): Ministry of Health; 2024 Apr 11 [cited 2025 Oct 29]. Available from: https://www.gov.br/saude/pt-br/assuntos/saude-com-ciencia/noticias/2024/abril/a-ciencia-garante-vacinas-contra-hpv-sao-seguras-e-protegem-criancas-e-adolescentes
Brazil. Ministry of Health. Practical guide on HPV: questions and answers [Internet]. Brasília: Ministry of Health; 2017 [cited 2025 Oct 29]. Available from: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/h/hpv/guia-pratico-sobre-hpv-perguntas-e-respostas
Brazil. Ministry of Health. Vaccination Coverage Dashboard (SAGE/MS) [Internet]. Brasília: Ministry of Health; 2024 [cited 2025 Oct 29]. Available from: https://sage.saude.gov.br
Brazil. Ministry of Health. Vaccination Coverage Dashboard [Internet]. Brasília: Ministry of Health; 2025 [cited 2025 Oct 20]. Available from: https://infoms.saude.gov.br/extensions/SEIDIGI_DEMAS_VACINACAO_CALENDARIO/SEIDIGI_DEMAS_VACINACAO_CALENDARIO.html
Brazil. Federal Government. Decline in HPV vaccination coverage represents a risk of increased preventable cancer cases in Brazil [Internet]. Brasília: Ministry of Health; 2023 [cited 2025 Oct 29]. Available from: https://www.gov.br/saude/pt-br/assuntos/noticias/2023/queda-da-cobertura-vacinal-contra-o-hpv-representa-risco-de-aumento-de-canceres-evitaveis-no-brasil
Pan American Health Organization. Recommendations on the use of the single-dose HPV vaccine [Internet]. Brasília: PAHO/WHO; 2024 [cited 2025 Oct 29]. Available from: https://www.paho.org/pt/noticias/20-12-2023-opas-oms-recomenda-esquema-dose-unica-vacina-contra-hpv
Reis RS, et al. HPV infection and cancer control in Brazil: the important role of vaccination. Rev Bras Cancerol. 2025;71(1):e164928. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/4928
World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem [Internet]. Geneva: World Health Organization; 2020 [cited 2025 Oct 29]. Available from: https://www.who.int/publications/i/item/9789240014107
Zanini NV, et al. Reasons for refusing the Human Papillomavirus vaccine among adolescents aged 11 to 14 years in the city of Maringá-PR. Rev Bras Med Fam Comunidade. 2017;12(39):1–13. Available from: https://rbmfc.org.br/rbmfc/article/view/1643
Glehn MP, et al. Human papillomavirus vaccination coverage in Northeast Brazil: a time series analysis, 2013–2021. Epidemiol Serv Saude. 2023;32(2):e2022790. Available from: https://www.scielosp.org/article/ress/2023.v32n2/e2022790/
Silva TM, et al. Impact of the COVID-19 pandemic on HPV vaccination coverage in Brazil. Int J Public Health. 2022;67:160495. Available from: https://pmc.ncbi.nlm.nih.gov
Bramer CA, et al. Decline in routine childhood vaccination coverage during the COVID-19 pandemic—worldwide, 2020–2021. Int J Public Health. 2022;67:1604224. doi:10.3389/ijph.2022.1604224
Santos WM, et al. HPV immunization in Brazil and proposals to increase vaccination coverage: a scoping review. Rev Saude Publica. 2023. Available from: https://www.scielo.br/j/rsp/a/VxL3HJ4cNvmFWKGVdrwTczK/
Wang J, et al. Predictors of human papillomavirus vaccination uptake: a systematic review. BMC Public Health. 2020;20:137. doi:10.1186/s12889-020-8228-5
Bruni L, et al. Impact of HPV vaccination on cervical cancer indicators in Brazil. Lancet Glob Health. 2024;12(2):e210–e218. doi:10.1016/S2214-109X(24)00023-4
Fregnani JHTG, et al. A school-based human papillomavirus vaccination program in Barretos, Brazil: final results of a demonstrative study. PLoS One. 2013;8(4):e62647. doi:10.1371/journal.pone.0062647
World Health Organization. Human papillomavirus vaccines: WHO position paper, December 2022 [Internet]. Wkly Epidemiol Rec. 2022;97(50):645–672 [cited 2025 Oct 29]. Available from: https://www.who.int/publications/i/item/who-wer9750-645-672Farias CC, et al. School-based HPV vaccination: challenges and perspectives in Brazil. Rev Bras Ginecol Obstet. 2020;42(7):421–428. doi:10.1055/s-0040-1712139
Brisson M, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis. Lancet Glob Health. 2024;12(2):e173–e182. doi:10.1016/S2214-109X(23)00538-7
Drolet M, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: updated systematic review. BMC Public Health. 2024;24:1785. doi:10.1186/s12889-024-1785-2
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2026 Ludmilla Bernardo Gomes, Thais Ranielle Souza de Oliveira, Lohany Christiny Campos Rodrigues, Kamila Araújo Santos, Giovana Martins Nonato Amaral Yung
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
